| Moshe Szyf|
| DNA Methylation and Cancer Therapy. Medical Intelligence Unit.|
Epigenetics, Cancer research
Moshe Szyf Wikipedia
Moshe Szyf is a geneticist and James McGill professor of pharmacology and therapeutics at the McGill University, where he also holds a GlaxoSmithKline-CIHR chair in pharmacology.
Szyf's main research interests lie with epigenetics, including behavioral epigenetics as well as cancer research.
Szyf received his Ph.D. from the Hebrew University on basic mechanisms of DNA methylation under supervision of Aharon Razin. Subsequently, he performed postdoctoral work at Harvard Medical School. In 1989, he was appointed as assistant professor in pharmacology and therapeutics at McGill University. In 2016, Moshe Szyf founded Montreal EpiTerapia Inc.Books
Moshe Szyf, DNA Methylation and Cancer Therapy, Springer, 2005, ISBN 978-0306478482
Moshe Szyf, Fundamentals of Epigenetics, Cambridge University Press, ISBN 978-0521898379
As of October 2013, Moshe Szyf published more than 140 papers in peer-reviewed journals, almost all on epigenetics. He is also on the Editorial Board of the journal Environmental Epigenetics, published by Oxford University Press.
Szyf also holds many patents, all relating to epigenetics-based therapeutics.